The EMA safety committee says tofacitinib should be used with caution in all patients at high risk for blood clots. News Alerts …read more October 31, 2019Post navigationPreviousPrevious post:Ask About Sex Life in Breast Cancer Patients on Endocrine TxNextNext post:Advisory Panel Backs New Contraceptive Patch Despite FDA Concerns
